NRXP

NRX Pharmaceuticals, Inc. - Common Stock (NRXP)

About NRX Pharmaceuticals, Inc. - Common Stock (NRXP)

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.

Details

Daily high

$3.39

Daily low

$3.29

Price at open

$3.37

52 Week High

$5.06

52 Week Low

$1.62

Market cap

143.7M

Dividend yield

Volume

380,010

Avg. volume

685,633

P/E ratio

-4.51

NRX Pharmaceuticals, Inc. - Common Stock News